pteridines has been researched along with Liver Neoplasms in 7 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most common therapy for estrogen receptor-positive breast cancer is antihormone therapy, such as tamoxifen." | 7.88 | Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer. ( Bui, QT; Hong, J; Im, JH; Jeong, SB; Kang, KW; Lim, SC; Shim, Y; Song, JM; Yoon, JH; Yun, J, 2018) |
| "The most common therapy for estrogen receptor-positive breast cancer is antihormone therapy, such as tamoxifen." | 3.88 | Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer. ( Bui, QT; Hong, J; Im, JH; Jeong, SB; Kang, KW; Lim, SC; Shim, Y; Song, JM; Yoon, JH; Yun, J, 2018) |
| "Hepatocellular carcinoma is a major cause of cancer mortality worldwide." | 1.56 | Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma. ( Eissa, LA; El-Mesery, ME; Habeeb, MR; Yousef, EH, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, L | 1 |
| Yao, K | 1 |
| Liu, K | 1 |
| Han, B | 1 |
| Dong, H | 1 |
| Zhao, W | 1 |
| Jiang, W | 1 |
| Qiu, F | 1 |
| Qu, L | 1 |
| Wu, Z | 1 |
| Zhou, B | 1 |
| Zhong, M | 1 |
| Zhao, J | 1 |
| Qiu, X | 1 |
| Zhong, L | 1 |
| Guo, X | 1 |
| Shi, T | 1 |
| Hong, X | 1 |
| Lu, S | 1 |
| Yousef, EH | 1 |
| El-Mesery, ME | 1 |
| Habeeb, MR | 1 |
| Eissa, LA | 1 |
| Jeong, SB | 1 |
| Im, JH | 1 |
| Yoon, JH | 1 |
| Bui, QT | 1 |
| Lim, SC | 1 |
| Song, JM | 1 |
| Shim, Y | 1 |
| Yun, J | 1 |
| Hong, J | 1 |
| Kang, KW | 1 |
| Li, HY | 1 |
| Luo, F | 1 |
| Li, XY | 1 |
| Fu, XF | 1 |
| He, JF | 1 |
| Tian, YZ | 1 |
| Zhu, JJ | 1 |
| Chu, XY | 1 |
| Zhao, HL | 1 |
| Massimi, M | 1 |
| Cardarelli, S | 1 |
| Galli, F | 1 |
| Giardi, MF | 1 |
| Ragusa, F | 1 |
| Panera, N | 1 |
| Cinque, B | 1 |
| Cifone, MG | 1 |
| Biagioni, S | 1 |
| Giorgi, M | 1 |
| Haupenthal, J | 1 |
| Bihrer, V | 1 |
| Korkusuz, H | 1 |
| Kollmar, O | 1 |
| Schmithals, C | 1 |
| Kriener, S | 1 |
| Engels, K | 1 |
| Pleli, T | 1 |
| Benz, A | 1 |
| Canamero, M | 1 |
| Longerich, T | 1 |
| Kronenberger, B | 1 |
| Richter, S | 1 |
| Waidmann, O | 1 |
| Vogl, TJ | 1 |
| Zeuzem, S | 1 |
| Piiper, A | 1 |
| Katoh, S | 1 |
| Sueoka, T | 1 |
| Hirayama, K | 1 |
| Masuda, I | 1 |
| Nakanishi, N | 1 |
| Yamada, S | 1 |
7 other studies available for pteridines and Liver Neoplasms
| Article | Year |
|---|---|
PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.
Topics: Animals; Antineoplastic Agents; Carcinogenesis; Carcinoma, Hepatocellular; Cell Cycle Proteins; Dise | 2020 |
Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellu | 2020 |
Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle | 2018 |
Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Proliferation; | 2019 |
Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival.
Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Cycli | 2017 |
Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Ce | 2012 |
[Phenylalanine hydroxylating activity in Tawa sarcoma].
Topics: Animals; Biopterins; Hydroxylation; Liver Neoplasms; Neoplasms, Experimental; Phenylalanine Hydroxyl | 1981 |